Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Dec 26, 2022; 10(36): 13250-13263
Published online Dec 26, 2022. doi: 10.12998/wjcc.v10.i36.13250
Figure 1
Figure 1 Kaplan-Meier curve of disease-free survival according to different subgroups. A: Age groups; B: Stage groups; C: History of hepatitis B groups.
Figure 2
Figure 2 Kaplan-Meier curves of disease-free survival in different age groups based on tumor node metastasis stage. A: Kaplan-Meier curves of disease-free survival (DFS) in different age groups based on I-II stage; B: Kaplan-Meier curves of DFS in different age groups based on III-IV stage.
Figure 3
Figure 3 Kaplan-Meier curves of disease-free survival in different stage groups based on age. A: Kaplan-Meier curves of disease-free survival (DFS) in different stage groups based on age ≥ 70 years; B: Kaplan-Meier curves of DFS in different stage groups based on age < 70 years.
Figure 4
Figure 4 Kaplan-Meier curves of disease-free survival in patients with a different history of hepatitis B based on tumor node metastasis stage. A: Kaplan-Meier curves of disease-free survival (DFS) in groups with a different history of hepatitis B based on I-II stage; B: Kaplan-Meier curves of DFS in groups with a different history of hepatitis B based on III-IV stage.
Figure 5
Figure 5 Nomogram for predicting disease-free survival of hepatocellular carcinoma patients after curative resection. TNM: Tumor node metastasis.
Figure 6
Figure 6 Calibration curves of the prognostic nomogram for disease-free survival in hepatocellular carcinoma patients. A: 3-year calibration curves of the prognostic nomogram for disease-free survival (DFS) in hepatocellular carcinoma (HCC) patients; B: 5-year calibration curves of the prognostic nomogram for DFS in HCC patients.
Figure 7
Figure 7 The receiver operator characteristic curves of the prognostic nomogram and tumor node metastasis stage. TNM: Tumor node metastasis.
Figure 8
Figure 8 The decision curve analysis curve of the prognostic nomogram for disease-free survival in hepatocellular carcinoma patients. A: 3-year decision curve analysis (DCA) curves of the prognostic nomogram for disease-free survival (DFS) in hepatocellular carcinoma (HCC) patients; B: 5-year DCA curves of the prognostic nomogram for DFS in HCC patients.